Peritoneal Neoplasms Clinical Trials

5 recruiting

Peritoneal Neoplasms Trials at a Glance

6 actively recruiting trials for peritoneal neoplasms are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Berlin, Montpellier, and Barcelona. Lead sponsors running peritoneal neoplasms studies include Assistance Publique - Hôpitaux de Paris, Corcept Therapeutics, and Eli Lilly and Company.

Browse peritoneal neoplasms trials by phase

Treatments under study

About Peritoneal Neoplasms Clinical Trials

Looking for clinical trials for Peritoneal Neoplasms? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peritoneal Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peritoneal Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

Ovarian NeoplasmsNeoplasm MetastasisFallopian Tube Neoplasms+1 more
Eli Lilly and Company1,080 enrolled260 locationsNCT07213804
Recruiting
Phase 2

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Ovarian CancerEndometrial CancerFallopian Tube Cancer+1 more
Corcept Therapeutics270 enrolled49 locationsNCT06906341
Recruiting
Not Applicable

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Postoperative ComplicationsHyperthermic Intraperitoneal ChemotherapyPeritoneal Neoplasms+2 more
Assistance Publique - Hôpitaux de Paris140 enrolled7 locationsNCT06351475
Recruiting
Phase 3

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

High-grade Serous Ovarian Carcinoma (HGSOC)Fallopian Tube NeoplasmsOvarian Neoplasm Epithelial+3 more
Swiss GO Trial Group540 enrolled53 locationsNCT04111978
Recruiting
Not Applicable

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

Fallopian Tube NeoplasmsCarcinoma, Ovarian EpithelialPeritoneal Neoplasms
Institut du Cancer de Montpellier - Val d'Aurelle300 enrolled1 locationNCT03976999
Recruiting

The Role of the Vascular Surgeon in Oncologic Surgery of Abdominal and Pelvic Retroperitoneal Masses

Retroperitoneal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna70 enrolled1 locationNCT06803251